2016 NLA Scientific Sessions Meeting Coverage
The NLA 2016 Scientific Sessions is underway. View featured highlights here. Visit the dedicated page from the NLA media partner Cardiology Today here.
This page was last updated: Nov 07, 2018
Dr. Joseph Witztum Receives W. Virgil Brown Distinguished Achievement Award,
Drs. Jonathan Cohen, Edward Fisher, and Helen Hobbs, Receive NLA Honorary Lifetime Award
Joyce Ross, CRNP, MSN, Assumes Role of President during the 2016 NLA Scientific Sessions in New Orleans
Jacksonville, Florida (May 26, 2016) — Joyce Ross, MSN, ANP, CLS, CRNP, FPCNA, FNLA, assumed her role as president of the National Lipid Association (NLA) during the business meeting held Saturday, May 21, 2016, in conjunction with the 2016 Scientific Sessions in New Orleans.
The NLA 2016 Scientific Sessions is underway. View featured highlights here. Visit the dedicated page from the NLA media partner Cardiology Today here.
This page was last updated: Nov 07, 2018
As we approach the half year mark of 2016, we are reminded once again of the tremendous support surrounding the Foundation of the NLA and its mission to reduce cardiovascular events and deaths through patient and clinician education. To help reach our goals, the Foundation is constantly finding new ways to get its message out and maintain interest in our charitable organization.
Wenliang Song, MD, is a third-year internal medicine resident at Bridgeport Hospital of Yale University. He has been a very active young member of the National Lipid Association (NLA). He is on the NELA Membership Committee and the Early Career Development Committee. Dr. Song recently took the initiative to promote awareness of the NLA through a “bottom up” strategy. He introduced the NLA to his residency program and received an extraordinary response.
It is a real privilege to serve as the president of the Northeast Lipid Association (NELA). Part of that privilege is having a bird’s eye view of all of the wonderful things the NELA membership is doing. As the president, I feel that my main contributions have been to provide a word of encouragement here or a suggestion there.
The intent of this article is to review the over-the-counter (OTC) products and dietary supplements that have proven effective on cholesterol levels. There is little direct evidence of how these supplements affect cardiovascular outcomes. Additionally, the dosage forms, recommended daily dosage, and content of these products often vary among manufacturers.
Structure, Function, Dietary Sources
There is an impressive portfolio of evidence-based dietary recommendations for cardiovascular disease (CVD) risk reduction, including those from the American Heart Association/American College of Cardiology (AHA/ACC)1 and the National Lipid Association (NLA),2 and for health promotion (2015–2020 Dietary Guidelines for Americans – DGAs).3 Despite evidence-based recommendations, there are ongoing controversies about diet and disease that pervade both the popular media and scientific literature.
Coconut oil consumption is rapidly increasing. This increase is in part because of supposed health benefits, including relieving mental fatigue and depression, altering risk factors of cardiovascular disease, and modifying cognition.1 Despite limited evidence for these purported benefits, consumption and therefore demand in the food industry is rising.2